Santhera reports positive results from LIONHEART study with Agamree demonstrating unique mineralocorticoid receptor ...
Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company, announces the positive outcome of the LIONHEART study, confirming vamorolone’s distinctive action also as a mineralocorticoid receptor antagonist, setting it apart from other …